Thomas Miller Investment Appoints Private Client Partner
Thomas Miller Investment, a member of the 129 year old Thomas Miller Group of companies, has appointed Matthew Brown as Private Client Partner to help drive the growth of Thomas Miller Investment's wealth management services in London.
Matthew previously worked at Broadstone Group before its acquisition by Thomas Miller Investment, where he was Executive and Retirement Services Director, having joined the firm in September 2006. Matthew has more than 10 years experience in financial services, in a variety of investment and consulting roles.
Matt Phillips, Managing Director at Thomas Miller Wealth Management, says:
"We are delighted to welcome Matthew to the team. This is an exciting time for Thomas Miller Wealth Management as we expand our private client offerings and reach. Matthew's expertise will enhance the services we provide to our clients and help us strengthen the quality of our financial advice.
"We look forward to working with Matthew as we continue to grow Thomas Miller Wealth Management into a leading financial planning business."
Matthew Brown added: "I am delighted to have joined the Thomas Miller Wealth Management team and look forward to developing their private client services."
Thomas Miller Investment has funds under management of over £2.9 billion and provides investment management services for private clients, insurance mutuals, charities, pension schemes and government.
Tags
You may also be interested in:
Thomas Miller were represented at the Sierra Leone Marathon for a second year, supporting corporate charity partner Street Child
Thomas Miller intends to appoint Hugh Titcomb as its new Chief Executive, subject to shareholder approval, replacing Bruce Kesterton
Thomas Miller appointed as manager of three established discretionary mutuals, Fire & Rescue Indemnity Company (FRIC), Livery Companies’ Mutual (LCM) and AIM.
Thomas Miller Investment (TMI) has announced that it is to appoint David Smith as its new Chief Executive, subject to regulatory approval.